Vaccine Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Vaccine Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Immunization
Investigators at Xi'an Jiao Tong University have published new data on immunization
September 24th, 2008
Data detailed in 'A cost-effectiveness analysis of universal childhood hepatitis A vaccination in China' have been presented. "The socioeconomic improvement has impacted hepatitis A virus (HAV) infection with a shift from high to intermediate endemicity in many parts of China. The first China-developed inactivated hepatitis A vaccine, with significantly low price, was licensed in 2002, prompting us to evaluate whether universal childhood vaccination is advisable now in China," scientists writing in the journal Vaccine report. "We considered vaccination scheduled at ages 12 and 18 months for all healthy children, and assumed that a single cohort was enrolled in...
Source: Vaccine Weekly (2008-09-24)
|
